2023 In Review: Major Developments In The Field Of Endocrinology Dr Akhil Krishna26 Dec 2023 11:15 AM IST Let us take a glimpse into the notable progress and accomplishments within the field of endocrinology for the year 2023. This overview showcases...
Evergreen Talk Series: Linagliptin and Dapagliflozin combination for T2DM with Cardiovascular risk or established ASCVD MD Brand Connect21 Dec 2023 11:45 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr. Sameer I. Dani,...
Top Ten Landmark Trials Across Cardiology - Dr Nihar Mehta Dr Nihar Mehta20 Dec 2023 9:45 AM IST 1. Framingham Heart Study (1948): The inception of modern cardiovascular epidemiology, the Framingham Heart Study, laid the foundation for...
Acute Pulpitis: Dental Practice Perspective and Application of Aceclofenac Paracetamol Combination Dr. Nandita Mohan14 Dec 2023 11:19 AM ISTTooth pulp, a complex connective tissue within teeth, comprises nerves, blood vessels, and various cell types. Pulpitis is referred to as inflammation...
Linagliptin and Dapagliflozin: Therapeutic Applicability in T2DM with High CV Risk Dr. Kamal Kant Kohli13 Dec 2023 11:48 AM ISTType 2 Diabetes Mellitus and Cardiovascular DiseaseType 2 diabetes mellitus (T2DM) prevalence has been increasing globally, particularly in India (1)...
Scope of Pre-probiotics as Add-On to PPIs in Different Clinical Indication: 1000+ Indian HCPs Opine Dr. Kamal Kant Kohli8 Dec 2023 12:00 PM ISTCo-prescription of probiotics with proton pump inhibitors (PPIs) decreases the potential side effects associated with long-term PPI use and improves...
Allergens in India and its Avoidance: Review through Indian Guidelines and Role of Fexofenadine-Montelukast Combination Dr. Kamal Kant Kohli4 Dec 2023 12:13 PM ISTAllergic rhinitis is one of the most common allergic diseases, which appears to increase in India. Risk factors, diagnosis, and AR management vary...
First Indian Evidence: Triple FDC (DAPA, SITA, MET ER) Yields Better HbA1c Reduction in T2DM Patients Uncontrolled on Existing Therapy Dr. Kamal Kant Kohli2 Dec 2023 11:43 AM ISTAn approach of using a once-daily triple fixed-dose combination of dapagliflozin, sitagliptin, and metformin ER (extended-release) in Indian type 2...
Evergreen Talk Series: Clinical applicability of Linagliptin in T2DM across CKD spectrum and Dapagliflozin up to CKD stage 4 MD Brand Connect1 Dec 2023 11:17 AM IST Advertisement Presenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and...
Dental Intervention Procedures: Challenges, Management and Role of Aceclofenac, Paracetamol and Serratiopeptidase Based Combination Treatment Dr. Nandita Mohan25 Nov 2023 12:28 PM ISTDental intervention procedures encompass a comprehensive array of treatments conducted by dental professionals to maintain oral health, address dental...
Safety of Ranitidine: A Fresh Look at an Old Gem Dr. Kamal Kant Kohli23 Nov 2023 11:09 AM ISTThe introduction of histamine type 2 receptor antagonists (H2RAs) has revolutionised the management of acid-related disorders. Ranitidine has been...
Linagliptin and Dapagliflozin: Evidence for Robust Glycemic Control and Reaping CV-CKD Benefits in T2DM (EVERGREEN) Practice Perspective Dr. Kamal Kant Kohli21 Nov 2023 12:14 PM ISTType 2 diabetes mellitus (T2DM) is growing alarmingly due to rapid urbanization, migration, aging population, and lifestyle changes; with Asia being...
